pindolol   Click here for help

GtoPdb Ligand ID: 91

Synonyms: betapindol | LB-46 | Visken®
Approved drug
pindolol is an approved drug (FDA (1982))
Compound class: Synthetic organic
Comment: Pindolol is a nonselective beta blocker.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 3
Rotatable bonds 6
Topological polar surface area 57.28
Molecular weight 248.15
XLogP 1.92
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(COc1cccc2c1cc[nH]2)CNC(C)C
Isomeric SMILES OC(COc1cccc2c1cc[nH]2)CNC(C)C
InChI InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3
InChI Key JZQKKSLKJUAGIC-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
β1-adrenoceptor Hs Antagonist Partial agonist 8.6 – 9.7 pKi - 3-8,11-12,14,16
⤷ pKi 8.6 – 9.7 [3-8,11-12,14,16]
β2-adrenoceptor Hs Antagonist Partial agonist 8.6 – 9.5 pKi - 3-5,7,16
⤷ pKi 8.6 – 9.5 [3-5,7,16]
β1-adrenoceptor Primary target of this compound Hs Agonist Partial agonist 8.5 – 9.3 pKi - 3-8,11-12,14,16
⤷ pKi 8.5 – 9.3 [3-8,11-12,14,16]
β2-adrenoceptor Primary target of this compound Hs Agonist Partial agonist 8.3 – 9.5 pKi - 3-5,7,11,14,16
⤷ pKi 8.3 – 9.5 [3-5,7,11,14,16]
5-HT1A receptor Hs Antagonist Antagonist 8.1 pKi - 15
⤷ pKi 8.1 [15]
β3-adrenoceptor Hs Agonist Partial agonist 7.1 – 8.0 pKi - 2-3,5,10-11
⤷ pKi 7.1 – 8.0 [2-3,5,10-11]
β3-adrenoceptor Hs Antagonist Partial agonist 7.1 – 8.0 pKi - 3,10-11,16
⤷ pKi 7.1 – 8.0 [3,10-11,16]
5-HT2B receptor Hs Agonist Full agonist 5.7 pKi - 13
⤷ pKi 5.7 [13]
5-HT2B receptor Hs Antagonist Antagonist 5.7 pKi - 13
⤷ pKi 5.7 [13]
5-HT2A receptor Hs Agonist Full agonist 5.0 pKi - 13
⤷ pKi 5.0 [13]
5-HT2A receptor Hs Antagonist Antagonist 5.0 pKi - 13
⤷ pKi 5.0 [13]
β2-adrenoceptor Hs Agonist Partial agonist 9.1 – 9.7 pEC50 - 3-4,6-7,9
⤷ pEC50 9.1 – 9.7 [3-4,6-7,9]
β1-adrenoceptor Hs Agonist Partial agonist 8.5 – 9.1 pEC50 - 3-4,7-9,17
⤷ pEC50 8.5 – 9.1 [3-4,7-9,17]
β3-adrenoceptor Hs Agonist Partial agonist 5.7 – 7.4 pEC50 - 1,3,10
⤷ pEC50 5.7 – 7.4 [1,3,10]
Ligand mentioned in the following text fields